A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nintedanib Impurity 67 - Request Quote

Picture of Nintedanib Impurity 67

Nintedanib Impurity 67

SZ CAT No:SZ-N023097
CAS No
NA
Mol.F.
C26H21N3O6
Mol.Wt.
471.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Nintedanib Impurity 67 is chemically (Z)-2-((4-(((6-(Methoxycarbonyl)-2-oxoindolin-3-ylidene)(phenyl)methyl)amino)phenyl)(methyl)amino)-2-oxoacetic acid. Nintedanib Impurity 67 is supplied with detailed characterization data compliant with regulatory guideline. Nintedanib Impurity 67 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nintedanib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Nintedanib Impurity 67

Purchase Nintedanib Impurity 67

Nintedanib Impurity 67 suppliers

Nintedanib Impurity 67 manufacturers

Nintedanib Impurity 67 price

Order Nintedanib Impurity 67

Enquire Nintedanib Impurity 67

Nintedanib Impurity 67 cost

Nintedanib Impurity 67 Supplier

Nintedanib Impurity 67 Distributor

Nintedanib Impurity 67 for Method Validation

Nintedanib Reference Standard

Nintedanib Impurity 67 for ANDA Filing

Nintedanib Impurity 67 for Forced Degradation Studies

Nintedanib Impurity 67 Identification Standards

Nintedanib Impurity 67 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,